Drugs / Probiotic Supplement
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT03349528 | Dec 2018 → Dec 2026 expected | bipolar depression | Sheppard Pratt Health System | Active not recruiting | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT00364650 | Jul 2006 → Dec 2009 | inflammatory diarrhea | Swedish Medical Center | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Probiotic Supplement | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00364650 ↗ |
| Modality | Other / unclassified | “food supplement probiotic consisting of high amounts of six strains of lactic acid bacteria normally found in the human colon” NCT00364650 ↗ |
| Route | Oral | “Probiotic supplement 1 tablet by mouth daily” NCT03349528 ↗ |